3rd Quarter - Report

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
$40,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Rare disease initiatives. Affordable Care Act (ACA) Issues and Enhancements.

LobbyistCovered position, as disclosed
CORINNE ALBERTS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Medicare/Medicaid MMM

Medicare / Medicaid issues impacting patients with rare diseases.

LobbyistCovered position, as disclosed
CORINNE ALBERTS —
HEIDI ROSS —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Rare Disease Trial Design. Prescription Drug User Fee Act (PDUFA) Reauthorization. User Fee Agreements. Clinical Trial Diversity. Patient-focused drug development.

LobbyistCovered position, as disclosed
CORINNE ALBERTS —
KARIN HOELZER New —
HEIDI ROSS —

Contacted: Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.